Article
Paclitaxel improves thrombopoiesis in the absence of thrombopoietin receptor (Mpl).
Journal of thrombosis and haemostasis : JTH - 1 Dec 2024
Meng Panpan, Liu Wenyu, Lao Jiawen, Liu Xunwei, Zhang Yangping, Sun Ying, Zhou Riyang, Du Changhong, Wang Junping, Zhao Dejian, Lin Qing, Zhang Yiyue
Abstract excerpt
BACKGROUND: Platelets are critical for thrombosis and hemostasis. The THPO-MPL pathway is the primary pathway for generating thrombocytes. Dysregulation of thrombopoiesis results in platelet formation and/or function-related disorders, such as thrombocytopenia. Paclitaxel is an extensively utilized chemotherapeutic agent and its activity may be related to platelets, but the effect of paclitaxel on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
